Research Analysts Set Expectations for ELVN FY2025 Earnings
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) – Research analysts at Lifesci Capital lifted their FY2025 EPS estimates for Enliven Therapeutics in a research note issued on Monday, March 17th. Lifesci Capital analyst S. Slutsky now anticipates that the company will post earnings of ($2.54) per share for the year, up from their previous forecast […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) – Research analysts at Lifesci Capital lifted their FY2025 EPS estimates for Enliven Therapeutics in a research note issued on Monday, March 17th. Lifesci Capital analyst S. Slutsky now anticipates that the company will post earnings of ($2.54) per share for the year, up from their previous forecast […]
